Visn. Nac. Akad. Nauk Ukr. 2015. (6): 11-19.

V.F. Chekhun
Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv

Information from scientific report at the meeting of Presidium of NAS of Ukraine
April 29, 2015

The main results of a number of unique complex researches and technology developments, which reveal not only the mechanisms of interaction of nanodimensional systems, but also create the platform for practical implementation of new diagnostic and therapeutic approaches into clinical practice, are presented.
Keywords: nanocomposites, tumor cells, vector delivery of drugs, drug resistance.


Language of article: ukrainian.


  1. Shpyleva S.I., Tryndyak V.P., Kovalchuk O., Starlard-Davenport A., Chekhun V.F., Beland F.A., Pogribny I.P. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res. Treat. 2011. 126(1): 63–71.
  2. Chekhun V.F., Lukyanova N.Yu., Burlaka A.P., Bezdenezhnykh N.A., Shpyleva S.I., Tryndyak V.P., Beland F.A., Pogribny I.P. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. Int. J. Oncology. 2013. 43(5): 1481–86.
  3. Antipova S.V., Shepil O.V., Lukianova N.Yu., Chekhun V.F. Relations between serum and tumor ferritin concentrations with sensitivity to neoadjuvant chemotherapy in breast cancer patients. Oncology (Onkologiya). 2013. 15(3): 204–09 [in Ukrainian].
  4. Chekhun V., Lukianova N., Demash D., Borikun T., Chekhun S., Shvets Yu. Manifestation of key molecular genetic markers in pharmacocorrection of endogenous iron metabolism in MCF-7 and MCF-7/DDP human breast cancer cells. CellBio. 2013. 3(4): 217–27.
  5. Chekhun V.F., Yurchenko O.V., Naleskina L.A., Demash D.V., Lukianova N.Yu., Lozovska Yu.V. In vitro modification of cisplatin cytotoxicity with magnetic fluid. Experimental oncology. 2013. 35(1): 15–19.
  6. Park K., Mrsny R.J. Controlled Drug Delivery: Present and Future. Controlled Drug Delivery. 2000. 752: 2–12.